Skip to content

SCT02 Clinical Accuracy Validation

Clinical Accuracy Validation for the Withings BeamO (SCT02) Smart Thermometer

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06637878
Acronym
WIBOFE
Enrollment
118
Registered
2024-10-15
Start date
2024-10-03
Completion date
2025-01-08
Last updated
2026-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fever

Brief summary

The aim of the study is to validate the accuracy of the temporal thermometer of Withings SCT02

Interventions

DEVICEInvestigational Device (Withings SCT02) temporal thermometer measurement

temperature measurement with investigational device (Withings SCT02)

DEVICEReference Device (Withings SCT01) temperature measurement

temperature measurement with reference device (Withings SCT01)

Sponsors

Withings
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. Consent: Demonstrates understanding of the study and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form. 2. Age: Participant age is among the categories 3. Compliance: Understands and is willing, able and likely to comply with all study procedures and restrictions.

Exclusion criteria

1. Personnel: An employee of the sponsor or the study site or members of their immediate family. 2. Medical Condition: 1. Preterm infants (current age plus length of gestation is less than 40 weeks) 2. Has taken antipyretic in previous 2 hours 3. Inflammation at the measurement site 4. Medical conditions that affect temperature readings (barbiturates, thyroid, antipsychotics, recent immunizations)

Design outcomes

Primary

MeasureTime frameDescription
Clinical Bias1 visitMean of the per-subject differences (Investigational - Reference), computed using the first measurement obtained from each subject with each device. A bias closer to 0 °F indicates closer agreement between devices; the sign indicates direction (a negative value means the investigational device read lower, on average, than the reference).
Limits of Agreement1 visitDefined per ISO (International Standards Organization) 80601-2-56 as 2 × the standard deviation of the per-subject (Investigational - Reference) differences. A smaller value indicates tighter agreement between the two devices around the mean bias.
Clinical Repeatability1 visitPooled standard deviation of three repeated measurements taken on the same subject with the investigational device, calculated as σr = √\[(σ1² + σ2² + … + σN²) / N\], where σi is the within-subject standard deviation of the three repeats for subject i and N is the number of subjects with repeated measurements. A smaller value (closer to 0 °F) indicates greater consistency of repeated measurements on the same subject.

Countries

United States

Participant flow

Recruitment details

Recruitment occurred at 5 clinical sites in the US from 8/31/2024 to 12/20/2024

Baseline characteristics

Characteristic
Age, Customized
0 to <3 months
15 Participants
Age, Customized
≥1 to <5 years
25 Participants
Age, Customized
≥3 months to <1 year
10 Participants
Age, Customized
≥5 years
24 Participants
Race and Ethnicity Not Collected0 Participants
Sex/Gender, Customized
Not Collected
0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1180 / 118
other
Total, other adverse events
0 / 1180 / 118
serious
Total, serious adverse events
0 / 1180 / 118

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 6, 2026